QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer

Name: QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer
License: Public Domain

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

ClinicalTrials.gov · Datasets · License: Public Domain

recurrent cervical cancer, metastatic cervical cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 424166
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.